Gar22 inhibitors are a class of compounds that specifically target the protein Gar22, a protein involved in cellular processes that regulate cell structure and motility. Gar22 plays a role in actin cytoskeleton dynamics, influencing how cells maintain their shape, migrate, and respond to environmental cues. It has been identified as part of a broader family of proteins that interact with actin filaments, contributing to the organization and stability of the cytoskeleton. The inhibition of Gar22 interferes with its ability to modulate actin polymerization and filament stability, which is crucial for cellular processes such as migration, adhesion, and division.
Researchers utilize Gar22 inhibitors to investigate the mechanisms underlying cytoskeletal regulation and cellular motility. By blocking Gar22 activity, these inhibitors can induce changes in cell morphology, migration patterns, and adhesion properties. This makes them valuable tools in studying cell movement, particularly in contexts such as wound healing, tissue development, and the response to mechanical stress. Furthermore, Gar22 inhibitors are employed in experiments that seek to unravel the complex signaling pathways that control cytoskeletal dynamics, shedding light on how cells reorganize their structural components in response to internal and external signals. Such research is critical for understanding the fundamental principles of cell behavior and how alterations in cytoskeletal regulation contribute to broader biological processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Paclitaxel stabilizes microtubules, potentially influencing GAS2L1 functions in cytoskeleton organization. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $230.00 $450.00 $1715.00 $2900.00 | 4 | |
Vinblastine destabilizes microtubules and may indirectly affect GAS2L1 activity by disrupting microtubule dynamics. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Nocodazole disrupts microtubule polymerization, potentially impacting GAS2L1-related processes. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Colchicine binds to tubulin, inhibiting microtubule polymerization, and may affect GAS2L1 indirectly. | ||||||
Docetaxel | 114977-28-5 | sc-201436 sc-201436A sc-201436B | 5 mg 25 mg 250 mg | $85.00 $325.00 $1072.00 | 16 | |
Docetaxel stabilizes microtubules, potentially affecting GAS2L1's role in microtubule dynamics. | ||||||
Eribulin | 253128-41-5 | sc-507547 | 5 mg | $865.00 | ||
Eribulin inhibits microtubule growth, potentially impacting processes regulated by GAS2L1. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporine, an immunosuppressant, can affect cell signaling pathways, potentially modulating GAS2L1 activities. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, could indirectly influence GAS2L1 by altering cellular growth and proliferation pathways. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib, a kinase inhibitor, may have broader effects potentially impacting pathways involving GAS2L1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, a proteasome inhibitor, affects protein degradation pathways, potentially influencing GAS2L1-related signaling. | ||||||